As the world becomes increasingly uncertain, Aehr Test Systems (AEHR) offers stability

The closing price of Aehr Test Systems (NASDAQ: AEHR) was $34.46 for the day, up 8.03% from the previous closing price of $31.90. In other words, the price has increased by $+2.56 from its previous closing price. On the day, 2929540 shares were traded. AEHR stock price reached its highest trading level at $34.98 during the session, while it also had its lowest trading level at $31.50.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



Our analysis of AEHR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 694.37. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 6.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 17 when SPORCK ALISTAIR N sold 499 shares for $28.79 per share. The transaction valued at 14,366 led to the insider holds 14,062 shares of the business.

DANESH FARIBA sold 2,330 shares of AEHR for $69,900 on Jan 13. The Director now owns 7,665 shares after completing the transaction at $30.00 per share. On Jan 13, another insider, ROSATI MARIO M, who serves as the Director of the company, sold 17,291 shares for $28.64 each. As a result, the insider received 495,154 and left with 50,067 shares of the company.

Valuation Measures:

As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 80.33, and their Forward P/E ratio for the next fiscal year is 31.19. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.64 while its Price-to-Book (P/B) ratio in mrq is 16.81.

Stock Price History:

Over the past 52 weeks, AEHR has reached a high of $32.04, while it has fallen to a 52-week low of $6.71. The 50-Day Moving Average of the stock is 24.44, while the 200-Day Moving Average is calculated to be 15.31.

Shares Statistics:

AEHR traded an average of 1.65M shares per day over the past three months and 2.23M shares per day over the past ten days. A total of 27.58M shares are outstanding, with a floating share count of 25.27M. Insiders hold about 4.90% of the company’s shares, while institutions hold 44.30% stake in the company. Shares short for AEHR as of Oct 13, 2022 were 3.44M with a Short Ratio of 4.58M, compared to 2.35M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 12.51% and a Short% of Float of 13.67%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.1 and a low estimate of $0.07, while EPS last year was $0.05. The consensus estimate for the next quarter is $0.16, with high estimates of $0.18 and low estimates of $0.15.

Analysts are recommending an EPS of between $0.56 and $0.52 for the fiscal current year, implying an average EPS of $0.54. EPS for the following year is $0.88, with 2 analysts recommending between $1.04 and $0.72.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $70.96M, while the lowest revenue estimate was $64.17M, resulting in an average revenue estimate of $67.57M. In the same quarter a year ago, actual revenue was $50.83M, up 32.90% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $101.18M in the next fiscal year. The high estimate is $102.89M and the low estimate is $99.47M. The average revenue growth estimate for next year is up 49.70% from the average revenue estimate for this year.